Neuronetics, Inc. Total Liabilities
Neuronetics, Inc. (STIM) had Total Liabilities of $109.89 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-11
- 2026-06-30: Liabilities $109.89M.
- 2026-03-31: Liabilities $108.38M.
- 2025-12-31: Liabilities $115.31M.
- 2025-09-30: Liabilities $114.11M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $109.89M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $108.38M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $115.31M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $114.11M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $103.14M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $102.46M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $109.10M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $190.40M 8-K/A · filed 2025-02-06 | $64.74M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $77.43M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $76.16M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $81.64M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $55.05M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $54.91M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $55.26M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $59.82M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $56.24M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $54.53M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $53.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $56.05M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $51.99M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $50.93M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $50.34M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $53.16M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $50.86M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $50.55M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $51.94M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $52.32M 10-K · filed 2021-03-02 | |
| 2019-09-30 | $51.15M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $49.61M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $48.02M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $45.98M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $42.63M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $46.48M 10-Q · filed 2018-08-14 | |
| 2017-12-31 | $44.45M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |